Kidney Care Chewable Tablet
Natural health product licensed in Canada
- Other names
- Cistanche Chewable Tablet, Desert Cistanche Tablet, Kidney Health Chewable Tablet, Roucongrong Chewable Tablet
- Licence holder
- CICTAN Health Group Corp.
- NPN or DIN-HM
- 80095903
- Status
- Active licence
- Licence date
- 4 December 2019
- Revision date
- Not provided
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Acide stéarique, Amidon alimentaire, modifié, Stéarate de magnésium, Xylitol, Saveur de bleuet, D-Mannitol, Acide citrique, Extrait de feuille de Stevia Rebaudiana
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Traditionally used in Traditional Chinese Medicine to tonify the kidney yang, replenish essence and blood, moisten the intestine to relax the bowels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Discontinue use and consult a health care practitioner If symptoms persist or worsen, or if new symptoms develop. Consult a health care practitioner prior to use if you are taking prescription medications.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. According to TCM, do not use on cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency.
Source
Official Health Canada record, licence 80095903
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.